Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72580 result(s) found, displaying 15626 to 15650

PARLODEL bromocriptine 2.5mg (as mesilate) tablet bottle Cancelled under Section 30(1)(c) of the Act

14 September 2023

Cancellation by sponsor

Requested by Sandoz Pty Ltd
Symbiotic Devices Pty Ltd - Collodion protectant Cancelled under Section 41GL(d) of the Act

14 September 2023

Cancellation by sponsor

Requested by Symbiotic Devices Pty Ltd
Dentalife Pty Ltd - Dental material, root canal sealing Cancelled under Section 41GL(d) of the Act

13 September 2023

Cancellation by sponsor

Requested by Dentalife Australia Pty Ltd
Dentalife Pty Ltd - Dental material, root canal sealing Cancelled under Section 41GL(d) of the Act

13 September 2023

Cancellation by sponsor

Requested by Dentalife Australia Pty Ltd
Voco Australia Pty Ltd - Mixer, dental, impression material Cancelled under Section 41GL(d) of the Act

13 September 2023

Cancellation by sponsor

Requested by Voco Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 10 microgram/0.4mL injection syringe Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 100 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 15 microgram/0.38mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 150 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 200 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 40 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 50 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 500 microgram/1.0mL solution for injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 60 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
ANGEVOUR darbepoetin alfa (rch) 80 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by Amgen Australia Pty Ltd
Emagin Pty Ltd - Prosthesis, internal, eye, intracorneal ring Cancelled under Section 41GL(d) of the Act

11 September 2023

Cancellation by sponsor

Requested by Emagin Pty Ltd
Juice Plus+ Berry Blend Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by The Juice Plus Company Australia Pty Ltd
NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 September 2023

Cancellation by sponsor

Requested by ORGANON PHARMA PTY LTD
Teleflex Medical Australia Pty Ltd - Scalp clip applier, reusable Cancelled under Section 41GL(d) of the Act

11 September 2023

Cancellation by sponsor

Requested by Teleflex Medical Australia Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

PARLODEL bromocriptine 2.5mg (as mesilate) tablet bottle Cancelled under Section 30(1)(c) of the Act

Symbiotic Devices Pty Ltd - Collodion protectant Cancelled under Section 41GL(d) of the Act

Dentalife Pty Ltd - Dental material, root canal sealing Cancelled under Section 41GL(d) of the Act

Dentalife Pty Ltd - Dental material, root canal sealing Cancelled under Section 41GL(d) of the Act

Voco Australia Pty Ltd - Mixer, dental, impression material Cancelled under Section 41GL(d) of the Act

ANGEVOUR darbepoetin alfa (rch) 10 microgram/0.4mL injection syringe Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 100 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 15 microgram/0.38mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 150 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 200 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 40 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 50 microgram/0.5mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 500 microgram/1.0mL solution for injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 60 microgram/0.3mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

ANGEVOUR darbepoetin alfa (rch) 80 microgram/0.4mL injection syringe with automatic needle guard Cancelled under Section 30(1)(c) of the Act

Emagin Pty Ltd - Prosthesis, internal, eye, intracorneal ring Cancelled under Section 41GL(d) of the Act

Juice Plus+ Berry Blend Cancelled under Section 30(1)(c) of the Act

NUVARING etonogestrel 11.7mg and ethinylestradiol 2.7mg vaginal drug delivery system Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 20/5 olmesartan medoxomil 20 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 40/10 olmesartan medoxomil 40 mg and amlodipine (as besilate) 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

OLMESARTAN/ AMLODIPINE - DSK 40/5 olmesartan medoxomil 40 mg and amlodipine (as besilate) 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

Teleflex Medical Australia Pty Ltd - Scalp clip applier, reusable Cancelled under Section 41GL(d) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?